Literature DB >> 23330679

Balance of Treg vs. T-helper cells in the transition from symptomless to lesional psoriatic skin.

R R M C Keijsers1, H M J van der Velden, P E J van Erp, R T de Boer-van Huizen, I Joosten, H J P M Koenen, P C M van de Kerkhof.   

Abstract

BACKGROUND: In the pathogenesis of psoriasis, proinflammatory T cells are strongly involved in the inflammatory process, where regulatory T-cell (Treg) function is impaired.
OBJECTIVES: As effective Treg function is associated with a numerical balance between Treg and effector T cells, we wondered whether Treg/T-helper cell ratios may be associated with certain stages of the inflammatory process. We opted for the margin zone model as a dynamic approach.
METHODS: From nine patients with chronic plaque psoriasis, 3-mm punch biopsies were obtained from the centre and margin of the lesion, perilesional skin and distant uninvolved skin. Skin biopsies of 10 healthy volunteers were included as a control. Samples were analysed using immunohistochemistry and immunofluorescence.
RESULTS: In the transition from symptomless to lesional skin, a significant increase of CD3+, CD4+ and Foxp3+ cells was found. In seven of nine patients the ratio of Treg (Foxp3+) vs. CD4+ T cells was higher in the distant uninvolved skin than in the perilesional and lesional skin. Interestingly, the Foxp3/CD4 ratio in the distant uninvolved skin was even higher than in the skin of healthy controls. Notably, we found that most of the interleukin (IL)-17 expression was not related to CD4+ cells, but to mast cells.
CONCLUSIONS: The relatively high Foxp3/CD4 ratio in symptomless skin of patients with psoriasis suggests an active immune controlling mechanism distant from the psoriatic plaque. In the margin and centre of the plaque the ratio appears skewed towards effector cells associated with inflammation. IL-17, an important driver of the psoriatic process, is mostly related to mast cells, and only sporadically to T cells.
© 2013 The Authors. BJD © 2013 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23330679     DOI: 10.1111/bjd.12236

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  15 in total

1.  Clinical improvement in psoriasis with specific targeting of interleukin-23.

Authors:  Tamara Kopp; Elisabeth Riedl; Christine Bangert; Edward P Bowman; Elli Greisenegger; Ann Horowitz; Harald Kittler; Wendy M Blumenschein; Terrill K McClanahan; Thomas Marbury; Claus Zachariae; Danlin Xu; Xiaoli Shirley Hou; Anish Mehta; Anthe S Zandvliet; Diana Montgomery; Frank van Aarle; Sauzanne Khalilieh
Journal:  Nature       Date:  2015-03-09       Impact factor: 49.962

Review 2.  Monoclonal antibodies inhibiting IL-12, -23, and -17 for the treatment of psoriasis.

Authors:  Caleb Jeon; Sahil Sekhon; Di Yan; Ladan Afifi; Mio Nakamura; Tina Bhutani
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

3.  In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing RORγt and IL-17.

Authors:  Romy R M C Keijsers; Anke G M Hendriks; Piet E J van Erp; Bram van Cranenbroek; Peter C M van de Kerkhof; Hans J P M Koenen; Irma Joosten
Journal:  J Invest Dermatol       Date:  2013-12-06       Impact factor: 8.551

Review 4.  Engineered antigen-specific regulatory T cells for autoimmune skin conditions.

Authors:  Zhussipbek Mukhatayev; Yekaterina O Ostapchuk; Deyu Fang; I Caroline Le Poole
Journal:  Autoimmun Rev       Date:  2021-01-18       Impact factor: 17.390

5.  Topical Application of Tetrandrine Nanoemulsion Promotes the Expansion of CD4+Foxp3+ Regulatory T Cells and Alleviates Imiquimod-Induced Psoriasis in Mice.

Authors:  Shaokui Chen; Zibei Lin; Tianzhen He; Md Sahidul Islam; Long Xi; Ping Liao; Yang Yang; Ying Zheng; Xin Chen
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

6.  Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis.

Authors:  Kristian Reich; Kim A Papp; Robert T Matheson; John H Tu; Robert Bissonnette; Marc Bourcier; David Gratton; Rodion A Kunynetz; Yves Poulin; Les A Rosoph; Georg Stingl; Wolfgang M Bauer; Janeen M Salter; Thomas M Falk; Norbert A Blödorn-Schlicht; Wolfgang Hueber; Ulrike Sommer; Martin M Schumacher; Thomas Peters; Ernst Kriehuber; David M Lee; Grazyna A Wieczorek; Frank Kolbinger; Conrad C Bleul
Journal:  Exp Dermatol       Date:  2015-05-08       Impact factor: 3.960

7.  Integrated computational approach to the analysis of RNA-seq data reveals new transcriptional regulators of psoriasis.

Authors:  Alena Zolotarenko; Evgeny Chekalin; Alexandre Mesentsev; Ludmila Kiseleva; Elena Gribanova; Rohini Mehta; Ancha Baranova; Tatiana V Tatarinova; Eleonora S Piruzian; Sergey Bruskin
Journal:  Exp Mol Med       Date:  2016-11-04       Impact factor: 8.718

Review 8.  The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis.

Authors:  Bogusław Nedoszytko; Magdalena Lange; Małgorzata Sokołowska-Wojdyło; Joanna Renke; Piotr Trzonkowski; Michał Sobjanek; Aneta Szczerkowska-Dobosz; Marek Niedoszytko; Aleksandra Górska; Jan Romantowski; Justyna Czarny; Jarosław Skokowski; Leszek Kalinowski; Roman Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2017-10-31       Impact factor: 1.837

Review 9.  Subsets of regulatory T cells and their roles in allergy.

Authors:  Huiyun Zhang; Hui Kong; Xiaoning Zeng; Lianyi Guo; Xiaoyun Sun; Shaoheng He
Journal:  J Transl Med       Date:  2014-05-12       Impact factor: 5.531

Review 10.  Stem Cells as Potential Candidates for Psoriasis Cell-Replacement Therapy.

Authors:  Agnieszka Owczarczyk-Saczonek; Magdalena Krajewska-Włodarczyk; Anna Kruszewska; Waldemar Placek; Wojciech Maksymowicz; Joanna Wojtkiewicz
Journal:  Int J Mol Sci       Date:  2017-10-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.